Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pediatric Pilonidal Sinus Surgical Treatment

The aim of study to evaluate four different treatment options for pilonidal sinus disease in a randomized controlled trial to find the most suitable treatment option.

Participants needed: 80
Trial details
Age: 12-18Biological sex: AllType: InterventionalSponsor: Zeliha AlicikusUpdated: Apr 14, 2026Locations: 1
Eligibility criteria

having sacrococcygeal pilonidal sinus disease [+1]

Being over 18 years old or under 12 years old [+1]

Status: Recruiting

Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion

This study aims to compare the incidence of thromboembolic complications among trauma patients receiving PCC, rFVIIa, both agents, or neither during massive transfusion. Secondary objectives include comparing mortality, transfusion requirements, intensive care unit (ICU) and hospital length of stay, ventilator-free days, and the incidence of transfusion-associated adverse events such as transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). Subgroup analyses will evaluate outcomes in patients with and without laboratory-confirmed TIC (INR \>1.2).

Participants needed: 4
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Zeliha AlicikusUpdated: Apr 14, 2026Locations: 2
Eligibility criteria

Adults ≥18 years [+2]

Traumatic cardiac injury [+4]

Status: Not yet recruiting

Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity

This study aims to compare the incidence and characteristics of peri-intubation adverse airway events in critically ill trauma patients with morbid obesity versus those with super obesity, and to determine whether increasing BMI independently predicts severe peri-intubation complications.

Participants needed: 2
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Zeliha AlicikusUpdated: Apr 14, 2026
Eligibility criteria

Age ≥ 18 years [+3]

Age < 18 years [+3]